Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecvayli
Tecvayli
Bi-weekly dose of Johnson & Johnson's blood cancer therapy gets US FDA approval
Reuters
Tue, 02/20/24 - 05:54 pm
JNJ
Tecvayli
FDA
Multiple Myeloma
J&J nabs FDA okay for BCMA bispecific Tecvayli
Pharmaphorum
Wed, 10/26/22 - 07:00 pm
JNJ
Multiple Myeloma
Tecvayli
FDA
J&J bags first nod for multiple myeloma bispecific to complement its own CAR-T offering
Fierce Pharma
Thu, 08/25/22 - 07:43 pm
JNJ
Europe
bispecific antibodies
Multiple Myeloma
Tecvayli
teclistamab